Howard G. Birnbaum

Economics, Econometrics and Finance · Social Sciences

63h-index16.5kcitations268works5.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Health Systems, Economic Evaluations, Quality of Life(59), Opioid Use Disorder Treatment(39), Healthcare Policy and Management(28), Mental Health Treatment and Access(25), Pain Management and Opioid Use(18)

Publications268 total

Economic Impact of Olanzapine Plus Fluoxetine Combination Therapy Among Patients Treated for Depression: A Pilot Study
Psychopharmacology Bulletin·2025· 5 cited
Measuring The Impact Of Air Pollution On Health Care Costs
Health Affairs·2020· 28 citedOpen Access
Direct Costs of Opioid Abuse in an Insured Population in the United States
Journal of Managed Care & Specialty Pharmacy·2020· 169 citedOpen Access
Cardiac arrhythmia detection outcomes among patients monitored with the Zio patch system: a systematic literature review
Current Medical Research and Opinion·2019· 58 citedOpen Access
Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer’s Disease
Journal of Alzheimer s Disease·2017· 23 citedOpen Access
Basal insulin initiation use and experience among people with type 2 diabetes mellitus with different patterns of persistence: results from a multi-national survey
Current Medical Research and Opinion·2017· 16 citedOpen Access
Drivers of excess costs of opioid abuse among a commercially insured population.
PubMed·2017· 7 cited
Perspectives of Comparative Effectiveness Research from the World of Decision Making
2017
Introducing Decision Making in a World of Comparative Effectiveness Research
2017· 1 cited
Perspectives on the Use of Comparative Effectiveness Research by Life Sciences Executives: An Interview with Mike Bonney
2017
Perspectives on the Use of Comparative Effectiveness Research by Life Sciences Executives: An Interview with a Senior Executive at an International Life Science Company
2017
Decision Making in a World of Comparative Effectiveness Research
2017· 18 cited
The Economic Burden of Opioid Abuse: Updated Findings
Journal of Managed Care & Specialty Pharmacy·2016· 83 citedOpen Access
Functional limitations and health care resource utilization for individuals with cognitive impairment without dementia: Findings from a United States population‐based survey
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring·2016· 25 citedOpen Access
Basal Insulin Persistence, Associated Factors, and Outcomes After Treatment Initiation: A Retrospective Database Study Among People with Type 2 Diabetes Mellitus in Japan
Diabetes Therapy·2016· 14 citedOpen Access
Reasons for Different Patterns of Basal Insulin Persistence after Initiation among People with Type 2 Diabetes Mellitus (T2DM)
Canadian Journal of Diabetes·2016· 1 cited
Real-World Treatment Patterns among Patients with Advanced Gastric Cancer in South Korea
Cancer Research and Treatment·2016· 23 citedOpen Access
Assessing the economic burden of Alzheimer’s disease patients first diagnosed by specialists
BMC Geriatrics·2016· 47 citedOpen Access
P2‐202: Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer’s Disease: Evidence from the National Alzheimer’s Coordinating Center Data
Alzheimer s & Dementia·2016
Excess Costs Associated with Possible Misdiagnosis of Alzheimer’s Disease Among Patients with Vascular Dementia in a UK CPRD Population
Journal of Alzheimer s Disease·2016· 18 citedOpen Access
page 1 of 14Next →

Frequent Co-authors

RN(19), Ronald C. Kessler(12), Alan G. White(7), Stephanie A. Leong(5), M. Schiller(5), Eric Q. Wu(5), Nathaniel P. Katz(5), Lizheng Shi(4), J. Bradford Rice(4), Jeff Schein(4), Rym Ben-Hamadi(3), Jasmina Ivanova(3), Kristina Secnik(3), Andrine R. Swensen(3), Crystal Pike(3), Yohanne Kidolezi(3), Ami Claxton(3), Milena N. Mareva(3), David Mallett(3), R.L. Robinson(3)